Both CD141+ DCs and CD1C+ DCs in tumors have the potential to differentiate into LAMP3+ DCs upon uptake of tumor antigens, although more CD141+ DC-derived LAMP3+ DCs have been observed in lung cancer (50, 78). This evidence concerns the gene LAMP3 and lung carcinoma.